Logo image
Spider-venom peptides as therapeutics
Journal article   Open access   Peer reviewed

Spider-venom peptides as therapeutics

N J Saez, S Senff, J E Jensen, S Y Er, Volker Herzig, L D Rash and G F King
Toxins, Vol.2(12), pp.2851-2871
2010
pdf
PDF - Published Version (Open Access)394.80 kBDownloadView
Published Version PDF - Published Version (Open Access) Open Access CC BY V3.0
url
https://doi.org/10.3390/toxins2122851View
Published Version

Abstract

spider venom peptide therapeutics drugs drug discovery cystine knot
Spiders are the most successful venomous animals and the most abundant terrestrial predators. Their remarkable success is due in large part to their ingenious exploitation of silk and the evolution of pharmacologically complex venoms that ensure rapid subjugation of prey. Most spider venoms are dominated by disulfide-rich peptides that typically have high affinity and specificity for particular subtypes of ion channels and receptors. Spider venoms are conservatively predicted to contain more than 10 million bioactive peptides, making them a valuable resource for drug discovery. Here we review the structure and pharmacology of spider-venom peptides that are being used as leads for the development of therapeutics against a wide range of pathophysiological conditions including cardiovascular disorders, chronic pain, inflammation, and erectile dysfunction.

Details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Web Of Science research areas
Food Science & Technology
Toxicology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image